RxDoctor Payments DataLook up a doctor →

Tina Nordeen, NP

Family · Aiken, SCNPI 1932789674

Payments from drug & device makers

$16,833in general payments, 2019–2025

Across 795 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lundbeck LLC$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • UCB, Inc.$1K
  • Neurocrine Biosciences, Inc.$997
  • AstraZeneca$929
  • plus $10K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie122$1,956
Lundbeck LLC45$1,149
Teva Pharmaceuticals USA, Inc.97$1,113
UCB, Inc.51$1,053
Neurocrine Biosciences, Inc.48$997
AstraZeneca(2 entities)25$929
Pfizer51$732
Argenx US, Inc.21$694
Novartis34$689
EMD Serono, Inc.22$641
Eisai Inc.26$636
Otsuka America Pharmaceutical, Inc.21$626
SK Life Science, Inc.22$585
Amgen21$506
Lilly USA, LLC28$463
Biohaven Pharmaceutical Holding Company Ltd.26$408
Acadia Pharmaceuticals Inc10$332
Biogen14$286
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$253
E.r. Squibb & Sons, L.L.C.2$246
Johnson & Johnson9$207
Acorda Therapeutics, Inc9$170
Mallinckrodt Hospital Products Inc.6$139
GSK1$125
ANI Pharmaceuticals, Inc.4$121
Astellas Pharma US Inc1$120
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$119
Alcresta Therapeutics, Inc.1$111
Novo Nordisk1$104
Grifols USA, LLC4$104
Neurelis, Inc.4$97
Ironwood Pharmaceuticals, Inc4$92
MDD US Operations, LLC4$81
Amneal Pharmaceuticals LLC4$79
Vanda Pharmaceuticals Inc.2$79
Supernus Pharmaceuticals, Inc.4$73
Kyowa Kirin, Inc.4$71
Sunovion Pharmaceuticals Inc.3$56
Braintree Laboratories, Inc.3$55
Inspire Medical Systems, Inc.2$49
Kedrion Biopharma, Inc.2$43
Banner Life Sciences, LLC2$41
Alnylam Pharmaceuticals Inc.2$39
Livanova USA, Inc.2$39
Genentech, Inc.1$38
Biohaven Pharmaceuticals, Inc.2$31
Impel Pharmaceuticals Inc.2$30
Gilead1$29
Bristol Myers Squibb2$29
Merck1$27
Sanofi1$26
Nestle Healthcare Nutrition Inc.1$23
Azurity Pharmaceuticals, Inc.1$21
Axsome Therapeutics, Inc.1$21
Jazz Pharmaceuticals Inc.1$20
Impel Pharmaceuticals LLC1$17
SPR Therapeutics, Inc1$12

How this compares

$16,833 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$49,304
Medicare patients
379
Services billed
487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Aiken

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →